The road to romiplostim approval and beyond

Oncology (Williston Park). 2009 Jul;23(8):709-10, 715.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carrier Proteins / therapeutic use*
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombopoietin

Substances

  • Carrier Proteins
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim